BMC Pharmacology and Toxicology, 2018 Background WHO pharmacovigilance indicators have been recommended as a useful tool towards improving pharmacovigilance activities. Nigeria with a myriad of medicines related issues is encouraging the growth of pharmacovigilance at peripheral centres ...
Abimbola O. Opadeyi +2 more
doaj +1 more source
Clinically important differences in the intensity of chronic refractory breathlessness [PDF]
, 2013 Context: Clinically important differences in chronic refractory breathlessness are ill defined but important in clinical practice and trial design.
Abernethy, Amy P. +4 more
core +2 more sources
Insights on the Evidence of Cardiotoxicity of Hydroxychloroquine Prior and During COVID‐19 Epidemic
Clinical and Translational Science, 2021 The recent empirical use of hydroxychloroquine (HCQ) in coronavirus disease 2019 (COVID‐19) revived the interest in its cardiac toxicity, increasingly sidelined over time.
Serena Romani +8 more
doaj +1 more source
Journal of Pharmacology and Pharmacotherapeutics, 2013 An increase in drug safety concerns in recent years with some high profile drug withdrawals have led to raising the bar by various stakeholders more importantly by the regulatory authorities. The number of Adverse Drug Reactions (ADRs) reported have also resulted in an increase in the volume of data handled and to understand pharmacovigilance a high ...
openaire +3 more sources
Getting antimalarials on target: impact of national roll-out of malaria rapid diagnostic tests on health facility treatment in three regions of Tanzania. [PDF]
, 2013 OBJECTIVES: Parasitological confirmation of malaria prior to treatment is recommended for patients of all ages, with malaria rapid diagnostic tests (mRDTs) an important tool to target artemisinin-based combination therapies (ACTs) to patients with ...
Bruxvoort, Katia +10 more
core +1 more source
Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada. [PDF]
, 2015 This survey analyzes two national pharmacovigilance databases in order to determine the major adverse reactions observed with the use of cholinesterase inhibitors in dementia.
Abagyan, Ruben +4 more
core +3 more sources
Proceedings of the biosimilars workshop at the International Symposium on Oncology Pharmacy Practice 2019. [PDF]
, 2020 The International Society of Oncology Pharmacy Practitioners organized a workshop to create learning opportunities on biosimilars in pharmacy practice on 10 October 2019.
Chan, Alexandre, Ke, Yu, Tan, Chia Jie
core
Infectious Diseases and TherapyIntroduction Understanding the differences between respiratory syncytial virus (RSV) subgroups A and B provides insights for the development of prevention strategies and public health interventions.
Charles Nuttens +7 more
doaj +1 more source
Challenges in pharmacovigilance
Indian Journal of Pharmacology, 2010 The National Pharmacovigilance Programme of India (NPVI) has recently been launched. A renewed effort, yet, a right step in the right direction, something that is our own, designed, funded, and executed by us. It deserves not only our best wishes, but also a wholehearted cooperation.
openaire +3 more sources
Profiling risk factors for chronic uveitis in juvenile idiopathic arthritis: a new model for EHR-based research. [PDF]
, 2013 BackgroundJuvenile idiopathic arthritis is the most common rheumatic disease in children. Chronic uveitis is a common and serious comorbid condition of juvenile idiopathic arthritis, with insidious presentation and potential to cause blindness. Knowledge
Bauer-Mehren, Anna +5 more
core +3 more sources